Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 3160

3160. Deputy Holly Cairns asked the Minister for Health if a decision not to reimburse a treatment Omaveloxolone sold under the brand name Skyclarys will be reviewed given it is the only pharmaceutical treatment available for treating Friedreich's Ataxia; and if she will make a statement on the matter. [26180/26]

askedIreland· Dáil Éireann· EN

Introduced

14 April 2026

Last action

Status

written

Sponsors

Subjects

Discovery layer

Source updated

14 April 2026

Summary

3160. Deputy Holly Cairns asked the Minister for Health if a decision not to reimburse a treatment Omaveloxolone sold under the brand name Skyclarys will be reviewed given it is the only pharmaceutical treatment available for treating Friedreich's Ataxia; and if she will make a statement on the matter. [26180/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.